The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney Disease
暂无分享,去创建一个
P. Houillier | B. Stengel | E. Letavernier | J. Haymann | M. Metzger | E. Daugas | F. Vrtovsnik | E. Thervet | M. Froissart | E. Vidal-Petiot | M. Flamant | J. Boffa | E. Rondeau | A. Karras | P. Ronco | H. Fessi | P. Ureña-Torres | C. Jacquot | M. Courbebaisse | C. d’Auzac | Lucile Mercadel | François Eric Martin Emmanuelle Christian Alexandre Eric Ch Vrtovsnik Daugas Flamant Vidal-Petiot Ja | D. E. E. G. Maruani | Pascal Houillier | P. Houillier | E. Thervet | P. Houillier
[1] Y. Le Marchand-Brustel,et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. , 2006, Gastroenterology.
[2] T. Ganz,et al. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[3] B. Stengel,et al. Timing and determinants of erythropoietin deficiency in chronic kidney disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[4] D. Swinkels,et al. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] M. Jadoul,et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. , 2009, Kidney international.
[6] J. Małyszko,et al. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients. , 2009, Transplantation proceedings.
[7] L. Kiemeney,et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. , 2011, Blood.
[8] L. N. Valenti,et al. Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. , 2012, World journal of nephrology.
[9] C. Eby,et al. Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients. , 2010, Kidney international.
[10] N. Akar,et al. Serum Pro-Hepcidin Levels and Relationship with Ferritin in Healthy Non-Anaemic Infants , 2007, Acta Haematologica.
[11] A. Nissenson,et al. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[12] D. Swinkels,et al. High‐sensitive radioimmunoassay for human serum hepcidin , 2009, British journal of haematology.
[13] H. Umehara,et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. , 2006, Blood.
[14] T. Shiigai,et al. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients , 2013, BMC Nephrology.
[15] D. Swinkels,et al. Hepcidin Serum Levels and Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis Patients , 2009, Acta Haematologica.
[16] N. Andrews,et al. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. , 2011, Blood.
[17] D. Girelli,et al. Hepcidin levels in chronic hemodialysis patients: a critical evaluation , 2014, Clinical chemistry and laboratory medicine.
[18] H. Rakugi,et al. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] D. Swinkels,et al. Hepcidin-25 in Chronic Hemodialysis Patients Is Related to Residual Kidney Function and Not to Treatment with Erythropoiesis Stimulating Agents , 2012, PloS one.
[20] E. Fung,et al. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. , 2014, Blood.
[21] K. Pantopoulos,et al. Regulation of iron transport and the role of transferrin. , 2012, Biochimica et biophysica acta.
[22] Olivier Moranne,et al. Timing of onset of CKD-related metabolic complications. , 2009, Journal of the American Society of Nephrology : JASN.
[23] C. Datz,et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. , 2009, Blood.
[24] J. Małyszko,et al. Hyporesponsiveness to Erythropoietin Therapy in Hemodialyzed Patients: Potential Role of Prohepcidin, Hepcidin, and Inflammation , 2009, Renal failure.
[25] L. Miranda,et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. , 2009, Journal of pharmacological and toxicological methods.
[26] D. Girelli,et al. The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis , 2013, BMC Nephrology.
[27] B. Stengel,et al. A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia , 2014, PloS one.
[28] J. Cook,et al. A clinical evaluation of serum ferritin as an index of iron stores. , 1974, The New England journal of medicine.
[29] D. Swinkels,et al. Tubular reabsorption and local production of urine hepcidin-25 , 2013, BMC Nephrology.
[30] J. McClung,et al. Hepcidin: A Critical Regulator of Iron Metabolism during Hypoxia , 2011, Advances in hematology.
[31] Jinghui Luo,et al. Association of Prohepcidin and Hepcidin-25 with Erythropoietin Response and Ferritin in Hemodialysis Patients , 2007, American Journal of Nephrology.